Medable is a leading global platform for decentralized clinical trials with a mission to reduce clinical trial timelines by 50 percent.
Medable connects patients, sites and clinical trial teams to improve patient access, experience, and outcomes.
Medable was founded in 2015 by Michelle Longmire and Tim Smith. The company is headquartered in Palo Alto, California, with an offices in Raleigh, North Carolina.
Medable is focused on building a unified platform for clinical trial execution, enabling patient generated data to drive clinical research, and precision and predictive medicine.
Medable's global decentralized trial platform streamlines design, recruitment, retention and data quality, replacing siloed systems with integrated digital tools, data and interfaces to accelerate trial execution.
Medable’s Digital Trial 360™ framework helps you design and optimize your protocol to leverage digital, gaining efficiencies across the clinical trial. The platform is now used by leading biopharma sponsors and clinical research organizations worldwide, and has been used for trials in 30+ countries and 26 languages.
Medable is backed by Sapphire Ventures, GSR Ventures, PPD, Inc., Streamlined Ventures and others. The company raised $91M in a Series C round on Nov 19, 2020. This brings Medable's total funding to $136.2M to date.